Internal and Emergency Medicine

, Volume 6, Issue 4, pp 307–314 | Cite as

Retinal vein occlusions: a review for the internist

  • Rossella Marcucci
  • Francesco Sofi
  • Elisa Grifoni
  • Andrea Sodi
  • Domenico Prisco
IM - Review

Abstract

Retinal vein occlusion (RVO) is a disease that is often associated with a variety of systemic disorders including arterial hypertension, diabetes mellitus, dyslipidemia and systemic vasculitis. There are various types of RVO, categorized on the basis of the site of occlusion and on the type of consequent vascular damage. Central retinal vein occlusion (CRVO) is the most clinically relevant type of RVO. In addition to well-known classical risk factors, new thrombophilic factors have been investigated in patients with RVO. Data concerning a number of the parameters remain contradictory; yet, hyperhomocysteinemia and vitamins involved in methionine metabolism appear to play a significant role in the pathogenesis of this disease. Alterations in the fibrinolysis pathway (elevated levels of PAI-1 and Lipoprotein (a)), together with haemorheologic modifications have been recently consistently associated with the disease. Medical treatment includes identification and correction of vascular risk factors. In addition, LMWHs appear to be the best therapeutic approach even if based on a limited number of trials, conducted on a limited number of patients. No data are available on the possible role of antithrombotic strategies in the long-term prevention of recurrent RVO or vascular events.

Keywords

Retinal vein occlusion Thrombophilia Risk factors Homocysteine 

Notes

Conflict of interest

None.

References

  1. 1.
    Prisco D, Marcucci R, Bertini L, Gori AM (2002) Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Intern Med 13:163–169PubMedCrossRefGoogle Scholar
  2. 2.
    Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P (2001) Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 131:61–77PubMedCrossRefGoogle Scholar
  3. 3.
    Hayreh SS, Zimmermann MG, Podhajsky P (1994) Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Opthalmol 117:429–441Google Scholar
  4. 4.
    Williamson T (1997) Central retinal vein occlusion: what’s the story? Br J Ophthalmol 81:698–704PubMedCrossRefGoogle Scholar
  5. 5.
    The Central Vein Occlusion Study Group (1993) Baseline and early natural history report. Arch Ophthalmol 111:1087–1095Google Scholar
  6. 6.
    The Central Vein Occlusion Study Group (1997) Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115:486–491Google Scholar
  7. 7.
    Cole MD, Dodson PM, Hendeles S (1989) Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension. Br J Ophthalmol 73:693–698PubMedCrossRefGoogle Scholar
  8. 8.
    Fong ACO, Schatz H, McDonald HR (1992) Central retinal vein occlusion in young adults (papillophlebitis). Retina 12:3–11PubMedCrossRefGoogle Scholar
  9. 9.
    The Eye disease case–control study group (1996) Risk factors for branch retinal vein occlusion. Am J Ophthalmol 116:286–296Google Scholar
  10. 10.
    The Eye disease case control study group (1996) Risk factors for central retinal vein occlusion. Arch Ophthalmol 114:545–554Google Scholar
  11. 11.
    Mitchell P, Smith W, Chang A (1996) Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountain Eye study. Arch Ophthalmol 114:1243–1247PubMedGoogle Scholar
  12. 12.
    Dodson PM, Kritzinger EE (1985) Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion. Trans Ophthalmol Soc UK 104:114–119PubMedGoogle Scholar
  13. 13.
    Prisco D, Marcucci R (2002) Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 32:308–311PubMedCrossRefGoogle Scholar
  14. 14.
    Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai AP, Poli D, Pepe G, Abbate R, Prisco D (2001) Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 86:772–776PubMedGoogle Scholar
  15. 15.
    Bandello F, Viganòd’Angelo S, Parlavecchia M et al (1994) Hypercoagulability and high lipoprotein(a) levels in patients with central retinal vein occlusion. Thromb Haemost 72:39–43PubMedGoogle Scholar
  16. 16.
    Graham SL, Goldberg L, Murray B, Beaumont P, Chong BH (1996) Activated protein C resistance: low incidence in glaucomatous disc hemorrhage and central retinal vein occlusion. Aust N Z Ophthalmol 24:199–205CrossRefGoogle Scholar
  17. 17.
    Salomon O, Moisseiev J, Rosenberg N (1998) Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coagul Fibrinolysis 9:617–622PubMedCrossRefGoogle Scholar
  18. 18.
    Linna T, Ylikorkay A, Kontula K, Puska P, Tervo T (1997) Prevalence of factor V Leiden in young adults with retinal vein occlusion. Thromb Haemost 77:212–216Google Scholar
  19. 19.
    Albisinni R, Coppola A, Loffredo M, Cerbone AM, Di Minno G, Greco GM (1998) Retinal vein occlusion and inherited conditions predisposing to thrombophilia. Thromb Haemost 80:702–703PubMedGoogle Scholar
  20. 20.
    Glueck CJ, Bell H, Vadlamani L, Heritable thrombophilia, hypofibrinolysis (1999) Possible causes of retinal vein occlusion. Arch Ophthalmol 117:43–49PubMedGoogle Scholar
  21. 21.
    Janssen MCH, den Heijer M, Cruysberg JRM, Wollersheim H, Bredie SJH (2005) Retinal vein occlusion: a form of venous thrombosis or a complications of atherosclerosis? Thromb Haemost 93:1021–1026PubMedGoogle Scholar
  22. 22.
    McGimpsey SJ, Woodside JV, Cardwell C, Cahill M, Chakravarthy U (2009) Homocysteine, methylenetetrahydrofolatereductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis. Ophthalmology 116:1778–1787PubMedCrossRefGoogle Scholar
  23. 23.
    Sodi A, Giambene B, Marcucci R, Sofi F, Bolli P, Abbate R, Prisco D, Menchini U (2008) Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion. Eur J Ophthalmol 18:233–238PubMedGoogle Scholar
  24. 24.
    Gori AM, Sofi F, Corsi AM et al (2006) Predictors of vitamin B6 and folate concentrations in older persons: the INCHIANTI study. Clin Chem 52:1318–1324PubMedCrossRefGoogle Scholar
  25. 25.
    Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg I (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693–2698PubMedCrossRefGoogle Scholar
  26. 26.
    Cattaneo M, Lombardi R, Lecchi A, Bucciarelli P, Mannucci PM (2001) Low plasma levels of vitamin B6 are independently associated with a heightened risk of deep vein thrombosis. Circulation 104:2442–2446PubMedCrossRefGoogle Scholar
  27. 27.
    Rimm EB, Willett WC, Hu FB (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279:359–364PubMedCrossRefGoogle Scholar
  28. 28.
    Terrazzi P, DI Micco P, Quaglia I (2005) Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B12 in patients with retinal vein occlusion. Thromb J 3:13–15CrossRefGoogle Scholar
  29. 29.
    Sofi F, Marcucci R, Bolli P, Giambene B, Sodi A, Fedi S, Menchini U, Gensini GF, Abbate R, Prisco D (2008) Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis 198:223–227PubMedCrossRefGoogle Scholar
  30. 30.
    Schoene NW, Chanmugam P, Reynolds RD (1986) Effect of oral vitamin B6 supplementation on in vitro platelet aggregation. Am J ClinNutr 43:825–830Google Scholar
  31. 31.
    Meydani SN, Hayek M, Coleman L (1992) Influence of vitamins E and B6 on immune response. Ann N Y Acad Sci 669:125–139PubMedCrossRefGoogle Scholar
  32. 32.
    Gori AM, Marcucci R, Fatini C, Gensini F, Sticchi E, Sodi A, Cappelli S, Menchini U, Gensini GF, Abbate R, Prisco D (2004) Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels. Thromb Haemost 92:54–60PubMedGoogle Scholar
  33. 33.
    Sofi F, Marcucci R, Fedi S, Giambene B, Sodi A, Menchini U, Gensini GF, Abbate R, Prisco D (2009) High lipoprotein(a) are associated with an increased risk of retinal vein occlusion. Atherosclerosis. doi:10.1016/j.atherosclerosis.2009.11.006
  34. 34.
    Carbone J, Sanchez-Ramon S, Cobo-Soriano R, Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders (2001) Comparison with ocular inflammatory diseases. J Rheumatol 28:2437–2441PubMedGoogle Scholar
  35. 35.
    Sofi F, Mannini L, Marcucci R, Bolli P, Sodi A, Giambene B, Menchini U, Gensini GF, Abbate R, Prisco D (2007) Role of haemorheological factors in patients with retinal vein occlusion. Thromb Haemost 98:1215–1219PubMedGoogle Scholar
  36. 36.
    Hansen LL, Wiek J, Wiederholt M (1989) A randomised prospective study of treatment of non-ischemic central retinal vein occlusion by isovolaemic hemodilution. Br J Ophthalmol 73:895–899PubMedCrossRefGoogle Scholar
  37. 37.
    Houtsmuller AJ, Vermeulen JA, Klompe M (1984) The influence of ticlopidine on the natural course of retinal vein occlusion. Agents Actions Suppl 15:219–229PubMedGoogle Scholar
  38. 38.
    Muravyov AV, Yakusevich VV, Surovaya L (2004) The effect of simvastatin therapy on hemorheological profile in coronary heart disease patients. Clin Hemorheol Microcirc 31:251–256PubMedGoogle Scholar
  39. 39.
    Martin SC, Butcher A, Martin N (2002) Cardiovascular risk assessment in patients with retinal vein occlusion. Br J Ophthalmol 86:774–776PubMedCrossRefGoogle Scholar
  40. 40.
    Cugati S, Wang JJ, Knudtson MD, Rochtchina E, Klein R, Klein BEK, Wong TY, Mitchell P (2007) Retinal vein occlusion and vascular mortality. Ophthalmology 114:520–524PubMedCrossRefGoogle Scholar
  41. 41.
    Hu CC, Ho JD, Lin HC (2009) Retinal vein occlusion and the risk of acute myocardial infarction: a 3-year follow-up study. Br J Ophthalmol 93:717–720PubMedCrossRefGoogle Scholar
  42. 42.
    Ho JD, Liou SW, Lin HC (2009) Retinal vein occlusion and the risk of stroke development: a five year follow-up study. Am J Ophthalmol 147:283–290PubMedCrossRefGoogle Scholar
  43. 43.
    Di Capua M, Coppola A, Albissini R, Tufano A, Guida A, Di Minno MND, Cirillo F, Loffredo M, Cerbone AM (2009) Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis. doi: 10.1007/s11239-009-0388-1
  44. 44.
    Squizzato A, Manfredi E, Bozzato S, Dentali F, Ageno W (2010) Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action. Thromb Haemost 103:271–276PubMedCrossRefGoogle Scholar
  45. 45.
    Ageno W, Cattaneo R, Manfredi E, Chelazzi P, Venco L, Ghiraduzzi A, Cimino L, Filippucci E, Ricci AL, Romanelli D, Incorvaia C, D’Angelo S, Campana F, Molfino F, Scannapieco G, Rubbi F, Imberti D (2010) Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double bind, controlled study. Thromb Res. doi:10.1016/j.thromres.2009.05.007
  46. 46.
    Farahvash MS, Moghaddam MM, Moghimi S et al (2008) Dalteparin in the management of recent onset central retinal vein occlusion: a comparison with acetylsalicylic acid. Can J Ophthalmol 43:79–83PubMedCrossRefGoogle Scholar
  47. 47.
    Farahvash MS, Moradimogadam M, Farahvash MM et al (2008) Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: a randomized clinical trial. Arch Iran Med 11:418–422PubMedGoogle Scholar
  48. 48.
    Kohner EM, Pettit JE, Hamilton AM (1976) Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J 1:550–553PubMedCrossRefGoogle Scholar
  49. 49.
    Hattenbach LO, Friedrich AC, Lerche R (2009) Retinal vein occlusion and low-dose fibrinolytic therapy: a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion. Retina 29:932–940PubMedCrossRefGoogle Scholar
  50. 50.
    Lazo-Langner A, Hawel J, Ageno W, Kovacs MJ (2010) Low molecular weigh heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials. Haematologica. doi:10.3324/haematol.2010.023614

Copyright information

© SIMI 2010

Authors and Affiliations

  • Rossella Marcucci
    • 1
  • Francesco Sofi
    • 1
  • Elisa Grifoni
    • 1
  • Andrea Sodi
    • 2
  • Domenico Prisco
    • 1
  1. 1.Department of Medical and Surgical Critical AreaUniversity of FlorenceFlorenceItaly
  2. 2.Eye ClinicUniversity of FlorenceFlorenceItaly

Personalised recommendations